跳至主要内容
临床试验/NCT01555398
NCT01555398已完成1 期

Open-label, Randomized Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Fenofibric Acid for HIP0901 Capsule in Healthy Male Subjects

Hanmi Pharmaceutical Company Limited1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
48
试验地点
1
主要终点
AUC of Fenofibric acid

研究概览

简要总结

The purpose of this study is to evaluate the effect of food on the pharmacokinetic characteristics of fenofibric acid for HIP0901 capsule.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male volunteers, age between 20 and 45
  • Informed of the investigational nature of this study and voluntarily agree to participate in this study
  • Weight>50kg, BMI of >18kg/m2 and <27kg/m2 subject

排除标准

  • Acute disease within 28 days prior to start of study drug administration
  • Use of any prescription medication within 14 days prior to Day 1
  • Use of any medication within 7 days prior to Day 1
  • Has a severe medical history of hypersensitivity to fibric acid derivative
  • Participation in another clinical study within 30 days prior to start of study drug administration

结局指标

主要结局

AUC of Fenofibric acid

时间窗: 0-96 hrs

Cmax of Fenofibric acid

时间窗: 0-96 hrs

次要结局

未报告次要终点

研究者

发起方
Hanmi Pharmaceutical Company Limited
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical Trial to Evaluate the Effect of Food on the... | 临床试验